Denise L. Jackson - 16 Aug 2023 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Aug 2023, 16:46:55 UTC
Prior SEC filing
12 May 2023
Next SEC filing
10 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Denise L. Jackson

Key filing fact

Denise L. Jackson filed Form 4 for AMN HEALTHCARE SERVICES INC (AMN) on 18 Aug 2023.

Key facts

  • This page summarizes Denise L. Jackson's Form 4 filing for AMN HEALTHCARE SERVICES INC (AMN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2023, 16:46.

Change

  • Previous filing in this sequence was filed on 12 May 2023.
  • Current net transaction value: -$456,522.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMN transaction

Common Stock

Award

Transaction value
$0
Shares
+11,375
Change %
+66%
Price
$0.000000
Shares after
28,693
Date
16 Aug 2023
Ownership
Direct
Footnotes
F1
AMN transaction

Common Stock

Tax liability

Transaction value
$456,522
Shares
-5,045
Change %
-18%
Price
$90.49
Shares after
23,648
Date
16 Aug 2023
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2023. The Company's Relative TSR measured in the 75th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

Footnote F2

Number of shares withheld for tax purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .